Results 41 to 50 of about 2,949,493 (224)

Specialized Pro-Resolving Lipid Mediators Distinctly Modulate Silver Nanoparticle-Induced Pulmonary Inflammation in Healthy and Metabolic Syndrome Mouse Models. [PDF]

open access: yesNanomaterials (Basel)
Individuals with chronic diseases are more vulnerable to environmental inhalation exposures. Although metabolic syndrome (MetS) is increasingly common and is associated with susceptibility to inhalation exposures such as particulate air pollution, the ...
Pitchai A   +4 more
europepmc   +2 more sources

Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19

open access: yesFrontiers in Immunology, 2021
The recent outbreak of SARS-CoV2 has emerged as one of the biggest pandemics of our century, with outrageous health, social and economic consequences globally.
Maria G. Balta   +3 more
doaj   +2 more sources

Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. [PDF]

open access: yesAdv Drug Deliv Rev, 2020
Persistent inflammation is the key aggravator in many cardiovascular diseases, including atherosclerosis, aneurysm, injury/reperfusion, thrombosis, and neointimal hyperplasia following surgical or percutaneous interventions.
Kim AS, Conte MS.
europepmc   +2 more sources

Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases

open access: yesScience Bulletin
Uncontrolled hyperactivation of the immune system is the central mechanism underlying the pathogenesis of autoimmune diseases. Timely control of the inflammatory response is essential to prevent inflammation progression and organ damage.
Qingxiang Zhang   +6 more
exaly   +2 more sources

Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators. [PDF]

open access: yesFront Immunol, 2022
Acute-on chronic liver failure (ACLF) is a syndrome that develops in patients with acutely decompensated cirrhosis (AD). It is characterized by a systemic hyperinflammatory state, leading to multiple organ failure. Our objective was to analyze macrophage
Sánchez-Rodríguez MB   +6 more
europepmc   +2 more sources

Reprogramming Inflammatory Macrophages with Specialized Pro-Resolving Lipid Mediators: A Novel Immunotherapeutic Strategy for Asthma [PDF]

open access: yesBiomedicines
Asthma is defined as a chronic airway inflammatory disorder with over-activation of the immune system accompanied by the inability to resolve inflammation.
Ruchita Tanu   +9 more
doaj   +2 more sources

The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery. [PDF]

open access: yesSci Rep, 2020
Obesity and diabetes are associated with chronic inflammation. Specialized pro-resolving lipid mediators (SPMs)—resolvins (Rv), protectins (PD) and maresins (MaR)—actively resolve inflammation.
Schulte F   +7 more
europepmc   +2 more sources

Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome

open access: yesChinese Medical Journal, 2018
Objective: Acute respiratory distress syndrome (ARDS) is an acute and lethal clinical syndrome that is characterized by the injury of alveolar epithelium, which impairs active fluid transport in the lung, and impedes the reabsorption of edema fluid from ...
Qian Wang   +3 more
doaj   +2 more sources

Specialized Pro-Resolving Mediators at the Ocular Surface: Biosynthesis, Mechanisms, and Therapeutic Potential

open access: yesBiology
Specialized pro-resolving mediators (SPMs) are endogenous lipid mediators that actively orchestrate the resolution of inflammation rather than relying solely on broad suppression of inflammatory signaling.
Siddharth Gandhi   +3 more
doaj   +2 more sources

Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications [PDF]

open access: yesFrontiers in Pharmacology, 2018
Diabetes and its associated chronic complications present a healthcare challenge on a global scale. Despite improvements in the management of chronic complications of the micro-/macro-vasculature, their growing prevalence and incidence highlights the ...
Monica de Gaetano   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy